Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuing Access to Axitinib (AG-013736, A406) for Patients from Previous Axitinib Trials
2005-000051-15Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of axitinib in Non-hematologic malignancy, sponsored by Pfizer. Primary endpoints: Safety assessment through adverse events monitoring and Safety assessment through laboratory values. Started Jun 2006; status: completed.
02
Drugs
axitinib
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on 2005-000051-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000051-15.